Total planned funding: $763,983,617
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $163,285,468 |
Kenya | $130,554,540 |
Uganda | $101,902,595 |
Zambia | $87,936,033 |
Tanzania | $78,025,424 |
Mozambique | $40,407,658 |
South Africa | $29,489,327 |
Zimbabwe | $24,370,558 |
Rwanda | $21,523,287 |
Côte d'Ivoire | $18,924,391 |
Democratic Republic of the Congo | $18,368,446 |
Haiti | $16,790,973 |
Botswana | $9,554,618 |
Ethiopia | $7,000,000 |
Burundi | $3,512,296 |
Namibia | $2,954,596 |
Vietnam | $2,850,000 |
West Africa Region | $2,012,397 |
Cameroon | $1,351,971 |
Eswatini | $894,359 |
Guyana | $772,197 |
Western Hemisphere Region | $706,942 |
Lesotho | $482,041 |
Asia Regional Program | $175,500 |
Malawi | $138,000 |
Organizational Types
Private Contractor | $575,536,994 |
Unknown | $54,764,135 |
Host Country Government Agency | $49,552,886 |
NGO | $47,241,115 |
FBO | $16,428,888 |
Implementing Agency | $14,411,415 |
University | $4,382,937 |
Parastatal | $1,073,626 |
Own Agency | $591,621 |
Program Areas
Treatment | $763,983,617 |
Budget Codes
HTXD: Treatment: ARV Drugs | $763,983,617 |
Top Partner Programs
Chemonics International:
$381,219,826
View countries